Trials / Not Yet Recruiting
Not Yet RecruitingNCT06999057
Quadriceps Motor Unit Adaptation to Simulated Knee Injury
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- University of Central Florida · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
This study investigates how simulated knee injury-via artificial joint effusion or deafferentation-affects quadriceps motor unit behavior in healthy young adults. Participants will complete neuromuscular testing during a single 2-hour lab session. This research seeks to improve understanding of muscle inhibition and inform interventions after real-world knee trauma.
Detailed description
Using a controlled laboratory model, the investigators will simulate knee injury through two methods: (1) intra-articular saline injection to induce effusion, and (2) intra-articular lidocaine injection to induce sensory deafferentation. Healthy participants aged 18-30 will undergo surface and decomposition EMG, isometric strength testing, and reflex measurements before and after the intervention. The primary outcome is motor unit recruitment characteristics, with secondary outcomes including quadriceps inhibition (Hoffmann reflex) and isometric peak torque. The findings will inform future neuromodulatory approaches in rehabilitation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Joint Effusion via 60 mL Sterile Saline | Injection of sterile saline into the knee joint to simulate joint swelling and induce quadriceps inhibition. |
| DRUG | Intra-articular Lidocaine | Injection of 7 mL lidocaine into the knee joint to simulate deafferentation by temporarily blocking sensory input. |
| OTHER | Sham injection | Simulated knee injection using a stage needle without skin penetration, used to blind participants and serve as control. |
Timeline
- Start date
- 2025-08-01
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2025-05-31
- Last updated
- 2025-05-31
Source: ClinicalTrials.gov record NCT06999057. Inclusion in this directory is not an endorsement.